Current Report Filing (8-k)
June 19 2018 - 10:42AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): June 19, 2018
IMMUDYNE, INC.
(Exact name of registrant as specified
in its charter)
Delaware
|
|
333-184487
|
|
76-0238453
|
(State or other Jurisdiction
of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
1460 Broadway
New York, NY
|
|
10036
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including
area code:
866-351-5907
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Cautionary Note Regarding Forward-Looking
Statements
This Current Report on Form 8-K includes
information that may constitute forward-looking statements. These forward-looking statements are based on the Company’s current
beliefs, assumptions and expectations regarding future events, which in turn are based on information currently available to the
Company. By their nature, forward-looking statements address matters that are subject to risks and uncertainties. Forward looking
statements include, without limitation, statements relating to projected industry growth rates, the Company’s current growth
rates and the Company’s present and future cash flow position. A variety of factors could cause actual events and results,
as well as the Company’s expectations, to differ materially from those expressed in or contemplated by the forward-looking
statements. Risk factors affecting the Company are discussed in detail in the Company’s filings with the Securities and Exchange
Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result
of new information, future events or otherwise, except to the extent required by applicable securities laws.
Item 7.01 Regulation FD Disclosure.
Pursuant to Regulation FD, Immudyne,
Inc. (the “Company”) hereby furnishes investor presentation materials in the form of a power point presentation and
description of the Company’s current platform technology (the “Presentation Material”) written by the Company
to update current shareholders as well potential investors of the Company’s business strategy. The Company will present the
Presentation Material to investors, shareholders and/or customers on or after June 19, 2018.
The information provided under this Item
7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is “furnished” and shall not be deemed “filed”
with the Securities and Exchange Commission or incorporated by reference in any filing under the Securities Exchange Act or 1934
or the Securities Act of 1933. The Presentation Material can also be found on our website at https://immudyne.com/.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
IMMUDYNE, INC.
|
|
(Registrant)
|
|
|
Date: June 19, 2018
|
By:
|
/s/ Justin Schreiber
|
|
Name:
|
Justin Schreiber
|
|
Title:
|
Chief Executive Officer
|
2